Science Explorer Interactive view Map
Company · Turku · Finland

Pharmatest (Finland)

Research works
85
▲ 37% vs 2013–17
Citations
816
9.5 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
31%
world 28%

Not ranked overall: Pharmatest (Finland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.32× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.56× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.59× its world share, 0 worksPharmacology, Toxico…Engineering: 0.06× its world share, 0 worksEngineeringHealth Professions: 0.21× its world share, 0 worksHealth ProfessionsMedicine: 4.15× its world share, 10 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.

Who are the top researchers at Pharmatest (Finland)?

Ranked on the composite score, Esa Alhoniemi and Jussi M. Halleen lead among researchers whose main affiliation is Pharmatest (Finland).

  1. 1 Esa Alhoniemi Finland · #306,963 worldwide 202 citations · 15 works
  2. 2 Jussi M. Halleen Finland · #457,593 worldwide 69 citations · 23 works
All ranked researchers at Pharmatest (Finland)

Which keywords describe research at Pharmatest (Finland)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Treatment, Prostate Cancer, Immunotherapy, Inflammation, Breast Cancer, Targeted Therapy, PET Imaging and Genetic Mutations.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Treatment16▲ 71×3 topics
  2. Prostate Cancer15▲ 114×2 topics
  3. Inflammation12▲ 5.9×19 topics
  4. Immunotherapy12▲ 21×6 topics
  5. Breast Cancer10▲ 41×5 topics
  6. Targeted Therapy8▲ 44×2 topics
  7. PET Imaging8▲ 43×3 topics
  8. Clinical Trials8▲ 15×4 topics
  9. Genetic Mutations8▲ 18×4 topics
  10. Biomarkers8▲ 15×4 topics
  11. Cancer8▲ 6.5×12 topics
  12. Clinical Practice Guidelines8▲ 16×6 topics
  13. Radioimmunotherapy8▲ 227×1 topic
  14. Radiopharmaceuticals8▲ 227×1 topic
  15. Hormone Therapy8▲ 84×3 topics
  16. Androgen Receptor7▲ 93×1 topic
  17. Bisphosphonates7▲ 221×1 topic
  18. Genomic Profiling7▲ 86×1 topic
  19. Osteonecrosis of the Jaw7▲ 221×1 topic
  20. Mesenchymal Stem Cells6▲ 59×2 topics
  21. Regeneration6▲ 39×2 topics
  22. Matrix Metalloproteinases6▲ 42×2 topics
  23. Cartilage6▲ 144×1 topic
  24. Osteoarthritis6▲ 53×1 topic
  25. Tumor Microenvironment5▲ 17×3 topics
  26. Bone Resorption4▲ 179×1 topic
  27. Osteoclast Differentiation4▲ 179×1 topic
  28. Tumor Targeting4▲ 33×2 topics
  29. Cardiovascular Risk4▲ 12×3 topics
  30. Tumor Metastasis3▲ 66×2 topics
  31. Epithelial-Mesenchymal Transition3▲ 44×2 topics
  32. Cancer Stem Cells3▲ 86×1 topic
  33. Colorectal Cancer3▲ 39×2 topics
  34. Drug Resistance3▲ 12×2 topics
  35. Gene Therapy3▲ 14×2 topics
  36. Parathyroid Hormone3▲ 36×2 topics
  37. Stem Cell Niches3▲ 86×1 topic
  38. Cyclooxygenase-2 Inhibitors3▲ 95×1 topic
  39. Prostaglandins3▲ 95×1 topic
  40. Bone Mineral Density3▲ 40×2 topics

Which research topics does Pharmatest (Finland) publish most on?

By volume in 2022–2025: Prostate Cancer Treatment and Research, Osteoarthritis Treatment and Mechanisms, Radiopharmaceutical Chemistry and Applications and Inflammatory mediators and NSAID effects.

  1. 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 2 works
  2. 2 Osteoarthritis Treatment and Mechanisms Rheumatology 2 works
  3. 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Inflammatory mediators and NSAID effects Pharmacology 1 works
  5. 5 Bone health and treatments Oncology 1 works
  6. 6 Bone Metabolism and Diseases Molecular Biology 1 works
  7. 7 Multiple Myeloma Research and Treatments Hematology 0 works
  8. 8 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Bone health and osteoporosis research Orthopedics and Sports Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.6%not open69.4%

World: 28% of research is openly available.

with international co-authors39.3%domestic only60.7%

World: 19% is written across borders.

How has Pharmatest (Finland)'s research output changed?

Output in 2018–2022 was 37% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Turku

All research institutions in Turku

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.